BioSpace News Archive

Pharm Country

DSM comments on a new study linking COVID-19 to increased risk of neurological disorders - Omega 3s to be a potential solution

Royal DSM, a global science-based company active in Health, Nutrition and Bioscience, comments on the findings from a recently published paper in Nature Medicine which reported that those infected with COVID-19 are at increased risk of long-term neurologic disorders that persist post infection.

November 29, 2022
·
4 min read
Deals

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.

November 29, 2022
·
8 min read
Biotech Beach

EpicentRx Awarded Funding from FightMND to Evaluate Therapeutic Potential of RRx-001 in Motor Neuron Disease (aka ALS)

EpicentRx Inc are pleased to announce that EpicentRx has been awarded funding from FightMND to evaluate the potential neuroprotective benefits of the company’s lead small molecule, RRx-001.

November 29, 2022
·
3 min read
Biotech Bay

Glassbeam Unveils High-Security Cloud Management Compliance Framework at RSNA 2022 for its Healthcare Analytics Solution for Connected Medical Equipment

Glassbeam, Inc. today announced it is in the final stages of releasing its cloud based platform SCALAR™ and Healthcare Application Suite Clinsights™ with NIST 800-53 controls and continuous monitoring security framework.

November 29, 2022
·
3 min read
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.

November 29, 2022
·
5 min read
Biotech Bay

Avail Medsystems to Participate in the Jefferies Virtual Private MedTech Summit

Avail today announced that Daniel Hawkins , Chief Executive Officer of Avail, will participate in a fireside chat at the Jefferies Virtual Private MedTech Summit on Tuesday, December 6, 2022 at 10:30 a.m. ET.

November 29, 2022
·
1 min read
BioForest

Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration

Cajal aims to accelerate neurodegeneration drug discovery by enabling target discovery and validation at unprecedented scale.

November 29, 2022
·
6 min read
Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase

Virios Therapeutics, Inc. today announced that Greg Duncan, Chairman and CEO of Virios Therapeutics will be attending and presenting at the Planet MicroCap Showcase, which is taking place virtually December 6 – 8, 2022.

November 29, 2022
·
4 min read
Drug Development

Inversago Pharma Doses First Patient in Phase 2 Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease

Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that the first patient has been dosed with INV-202 in a Phase 2 clinical trial in subjects with diabetic kidney disease (DKD).

November 29, 2022
·
3 min read
Business

Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer

Adicet Bio, Inc. today announced the appointment of Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer.

November 29, 2022
·
5 min read